BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21501826)

  • 1. The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism.
    Konradt C; Frigimelica E; Nothelfer K; Puhar A; Salgado-Pabon W; di Bartolo V; Scott-Algara D; Rodrigues CD; Sansonetti PJ; Phalipon A
    Cell Host Microbe; 2011 Apr; 9(4):263-72. PubMed ID: 21501826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type 3 secretion effector IpgD promotes S. flexneri dissemination.
    Köseoğlu VK; Jones MK; Agaisse H
    PLoS Pathog; 2022 Feb; 18(2):e1010324. PubMed ID: 35130324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of phosphoinositides by the
    Tran Van Nhieu G; Latour-Lambert P; Enninga J
    Front Cell Infect Microbiol; 2022; 12():1012533. PubMed ID: 36389142
    [No Abstract]   [Full Text] [Related]  

  • 4. Shigella flexneri regulation of ARF6 activation during bacterial entry via an IpgD-mediated positive feedback loop.
    Garza-Mayers AC; Miller KA; Russo BC; Nagda DV; Goldberg MB
    mBio; 2015 Mar; 6(2):e02584. PubMed ID: 25736891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Sun CH; Wacquier B; Aguilar DI; Carayol N; Denis K; Boucherie S; Valencia-Gallardo C; Simsek C; Erneux C; Lehman A; Enninga J; Arbibe L; Sansonetti P; Dupont G; Combettes L; Tran Van Nhieu G
    EMBO J; 2017 Sep; 36(17):2567-2580. PubMed ID: 28701483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of interactions among host and bacterial proteins and evaluation of their role early during Shigella flexneri infection.
    Miller KA; Garza-Mayers AC; Leung Y; Goldberg MB
    Microbiology (Reading); 2018 Apr; 164(4):540-550. PubMed ID: 29488864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella impairs T lymphocyte dynamics in vivo.
    Salgado-Pabón W; Celli S; Arena ET; Nothelfer K; Roux P; Sellge G; Frigimelica E; Bousso P; Sansonetti PJ; Phalipon A
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4458-63. PubMed ID: 23417297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology.
    Niebuhr K; Giuriato S; Pedron T; Philpott DJ; Gaits F; Sable J; Sheetz MP; Parsot C; Sansonetti PJ; Payrastre B
    EMBO J; 2002 Oct; 21(19):5069-78. PubMed ID: 12356723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
    Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection.
    Pendaries C; Tronchère H; Arbibe L; Mounier J; Gozani O; Cantley L; Fry MJ; Gaits-Iacovoni F; Sansonetti PJ; Payrastre B
    EMBO J; 2006 Mar; 25(5):1024-34. PubMed ID: 16482216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IcsA is a Shigella flexneri adhesin regulated by the type III secretion system and required for pathogenesis.
    Brotcke Zumsteg A; Goosmann C; Brinkmann V; Morona R; Zychlinsky A
    Cell Host Microbe; 2014 Apr; 15(4):435-45. PubMed ID: 24721572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of host cytoskeletal rearrangements by Shigella invasins.
    Lee JH; Park H; Park YH
    Int J Mol Sci; 2014 Oct; 15(10):18253-66. PubMed ID: 25310650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synaptojanin-homologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation.
    Marcus SL; Wenk MR; Steele-Mortimer O; Finlay BB
    FEBS Lett; 2001 Apr; 494(3):201-7. PubMed ID: 11311241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IpgD, a protein secreted by the type III secretion machinery of Shigella flexneri, is chaperoned by IpgE and implicated in entry focus formation.
    Niebuhr K; Jouihri N; Allaoui A; Gounon P; Sansonetti PJ; Parsot C
    Mol Microbiol; 2000 Oct; 38(1):8-19. PubMed ID: 11029686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling.
    Ramel D; Lagarrigue F; Pons V; Mounier J; Dupuis-Coronas S; Chicanne G; Sansonetti PJ; Gaits-Iacovoni F; Tronchère H; Payrastre B
    Sci Signal; 2011 Sep; 4(191):ra61. PubMed ID: 21934107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri.
    Espina M; Olive AJ; Kenjale R; Moore DS; Ausar SF; Kaminski RW; Oaks EV; Middaugh CR; Picking WD; Picking WL
    Infect Immun; 2006 Aug; 74(8):4391-400. PubMed ID: 16861624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shigella hijacks the exocyst to cluster macropinosomes for efficient vacuolar escape.
    Chang YY; Stévenin V; Duchateau M; Giai Gianetto Q; Hourdel V; Rodrigues CD; Matondo M; Reiling N; Enninga J
    PLoS Pathog; 2020 Aug; 16(8):e1008822. PubMed ID: 32866204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycan-Glycan Interaction Determines
    Belotserkovsky I; Brunner K; Pinaud L; Rouvinski A; Dellarole M; Baron B; Dubey G; Samassa F; Parsot C; Sansonetti P; Phalipon A
    mBio; 2018 Feb; 9(1):. PubMed ID: 29440574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.
    Picking WL; Nishioka H; Hearn PD; Baxter MA; Harrington AT; Blocker A; Picking WD
    Infect Immun; 2005 Mar; 73(3):1432-40. PubMed ID: 15731041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type three secretion system effector protein IpgB1 promotes Shigella flexneri cell-to-cell spread through double-membrane vacuole escape.
    Weddle EA; Köseoğlu VK; DeVasure BA; Agaisse HF
    PLoS Pathog; 2022 Feb; 18(2):e1010380. PubMed ID: 35202448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.